PharmDs Explain What Happens When You Mix CBD and Alcohol Together
Pharmacokinetic interactions CBD alcohol can affect how both substances are metabolized in the liver. Patients often combine CBD and alcohol without understanding potential risks. This article highlights clinical effects and safety considerations for…
Cannabis Pharmacokinetics Review: THC, CBD, Dosing
This paper is a broad evidence review of human pharmacokinetic studies on THC and CBD. It helps clarify how route, formulation, food, sex, drug interactions, and patient factors can meaningfully change absorption and exposure. Its main limitation is that…
Cannabidiol in Anorexia Nervosa: A Double-Blind Randomized Placebo Controlled Pilot Study to Test Safety, Pharmacokinetics, and Symptom Change.
This pilot study evaluates cbd anorexia nervosa safety in a randomized, placebo-controlled trial. It focuses on tolerability and pharmacokinetics in affected women. The findings provide preliminary safety data for future research.
Behavioural, Pharmacokinetic, and Genetic Evidence of CBD-Oxycodone Interaction in Mice
This study investigated cannabidiol oxycodone interaction and its effects on opioid analgesia and pharmacokinetics. Acute CBD administration increased oxycodone exposure and analgesic duration. Chronic use accelerated tolerance development specific to…
WCN26-5407 Pharmacokinetics of Cannabidiol in People with Kidney Failure
This article reviews pharmacokinetics cannabidiol kidney failure, highlighting important clinical considerations. Understanding CBD metabolism in kidney failure is critical for safe cannabis medicine use. Clinicians should monitor emerging evidence on…
Understanding Delta-8-THC Vaping Pharmacokinetics
This clinical study examines delta-8-thc vaping pharmacokinetics in humans, addressing a key knowledge gap. Findings suggest vaped delta-8-thc may be more potent than smoked cannabis. Understanding these effects is crucial for patient safety and clinical…
Cannabinoids and Drug-Drug Pharmacokinetic Interactions: Deciphering the Risks
Cannabinoid drug interactions clinical evidence highlights the importance of understanding how cannabinoids affect other medications. These interactions can alter drug metabolism and efficacy. Clinicians must consider these risks for safe prescribing and…
Marijuana Leaf and Vapes Now Accessible to Medical Cannabis Patients
Vapes available for medical cannabis patients provide rapid onset and precise dosing, enhancing therapeutic outcomes. This new bill expands access to vaporized cannabis, a preferred delivery method with distinct pharmacokinetics. Clinicians now have more…
Inside the FIRST Controlled Cannabis Airflow Trial with Dr. Allison Justice
The controlled cannabis airflow trial represents a breakthrough in standardizing inhalation dosing. This study focuses on improving pharmacokinetics for more predictable cannabis effects. Controlled cannabis airflow trial research is critical for…
Nexalis Launches Phase 1 Trial for CBD Metered-Dose Inhaler
Nexalis has initiated a Phase 1 trial focusing on CBD drug delivery pharmacokinetics using a metered-dose inhaler. This method aims to improve dosing precision and speed of onset compared to oral CBD. The trial represents a significant advancement in…
